(Q72549767)

English

Malignant lymphomas following allogenic disease: transition from an immunological to a neoplastic disorder

scientific article published on 01 September 1965

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

5828031

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5828031%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 October 2019

title

Malignant lymphomas following allogenic disease: transition from an immunological to a neoplastic disorder (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

5828031

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5828031%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 October 2019

author name string

R S Schwartz

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

5828031

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5828031%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 October 2019

L Beldotti

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

5828031

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5828031%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 October 2019

language of work or name

English

0 references

publication date

1 September 1965

1 reference

stated in

Europe PubMed Central

PubMed publication ID

5828031

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5828031%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference

Europe PubMed Central

PubMed publication ID

5828031

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5828031%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 October 2019

volume

149

1 reference

stated in

Europe PubMed Central

PubMed publication ID

5828031

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5828031%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 October 2019

issue

3691

1 reference

stated in

Europe PubMed Central

PubMed publication ID

5828031

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5828031%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 October 2019

page(s)

1511-1514

1 reference

stated in

Europe PubMed Central

PubMed publication ID

5828031

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5828031%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 October 2019

Identifiers

DOI

10.1126/SCIENCE.149.3691.1511

1 reference

stated in

Europe PubMed Central

PubMed publication ID

5828031

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5828031%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 October 2019

PubMed publication ID

5828031

1 reference

stated in

Europe PubMed Central

PubMed publication ID

5828031

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5828031%20AND%20SRC:MED&resulttype=core&format=json

(Q72549767)

Malignant lymphomas following allogenic disease: transition from an immunological to a neoplastic disorder

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)